Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Leonetti

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Frontiers in Chemistry|January 23, 2023
Editorial: Coumarins: New synthetic approaches and new pharmacological applicationsAngela Stefanachi, Giovanni Muncipinto, Francesco Leonetti
Molecules (Basel, Switzerland)|February 1, 2018
Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive CompoundsAngela Stefanachi, Francesco Leonetti, Leonardo Pisani, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2018
Ion Channels in Drug Discovery and Safety PharmacologyPaola Imbrici, Orazio Nicolotti, Francesco Leonetti, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 24, 2022
Virtual Reverse Screening Approach to Target Type 2 Cannabinoid ReceptorFulvio Ciriaco, Nicola Gambacorta, Francesco Leonetti, et al.
Journal of Chemical Information and Modeling|October 26, 2007
Screening of matrix metalloproteinases available from the protein data bank: insights into biological functions, domain organization, and zinc binding groupsOrazio Nicolotti, Teresa Fabiola Miscioscia, Francesco Leonetti, et al.
Expert Opinion on Drug Discovery|February 5, 2013
Computational methods for the design of potent aromatase inhibitorsAngelo Danilo Favia, Orazio Nicolotti, Angela Stefanachi, et al.
Journal of Chemical Information and Modeling|June 11, 2008
An integrated approach to ligand- and structure-based drug design: development and application to a series of serine protease inhibitorsOrazio Nicolotti, Teresa Fabiola Miscioscia, Andrea Carotti, et al.
Molecules (Basel, Switzerland)|September 17, 2020
Bcr-Abl Allosteric Inhibitors: Where We Are and Where We Are Going toFrancesca Carofiglio, Daniela Trisciuzzi, Nicola Gambacorta, et al.
Expert Opinion on Drug Discovery|June 1, 2012
Strategies of multi-objective optimization in drug discovery and developmentOrazio Nicolotti, Ilenia Giangreco, Antonellina Introcaso, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2018
Molecular Docking for Predictive ToxicologyDaniela Trisciuzzi, Domenico Alberga, Francesco Leonetti, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Frontiers in Chemistry|January 23, 2023
Editorial: Coumarins: New synthetic approaches and new pharmacological applicationsAngela Stefanachi, Giovanni Muncipinto, Francesco Leonetti
Molecules (Basel, Switzerland)|February 1, 2018
Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive CompoundsAngela Stefanachi, Francesco Leonetti, Leonardo Pisani, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2018
Ion Channels in Drug Discovery and Safety PharmacologyPaola Imbrici, Orazio Nicolotti, Francesco Leonetti, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 24, 2022
Virtual Reverse Screening Approach to Target Type 2 Cannabinoid ReceptorFulvio Ciriaco, Nicola Gambacorta, Francesco Leonetti, et al.
Journal of Chemical Information and Modeling|October 26, 2007
Screening of matrix metalloproteinases available from the protein data bank: insights into biological functions, domain organization, and zinc binding groupsOrazio Nicolotti, Teresa Fabiola Miscioscia, Francesco Leonetti, et al.
Expert Opinion on Drug Discovery|February 5, 2013
Computational methods for the design of potent aromatase inhibitorsAngelo Danilo Favia, Orazio Nicolotti, Angela Stefanachi, et al.
Journal of Chemical Information and Modeling|June 11, 2008
An integrated approach to ligand- and structure-based drug design: development and application to a series of serine protease inhibitorsOrazio Nicolotti, Teresa Fabiola Miscioscia, Andrea Carotti, et al.
Molecules (Basel, Switzerland)|September 17, 2020
Bcr-Abl Allosteric Inhibitors: Where We Are and Where We Are Going toFrancesca Carofiglio, Daniela Trisciuzzi, Nicola Gambacorta, et al.
Expert Opinion on Drug Discovery|June 1, 2012
Strategies of multi-objective optimization in drug discovery and developmentOrazio Nicolotti, Ilenia Giangreco, Antonellina Introcaso, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2018
Molecular Docking for Predictive ToxicologyDaniela Trisciuzzi, Domenico Alberga, Francesco Leonetti, et al.
Pageof 8